These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 33587820

  • 21. A Fully Automatic Method to Segment Choroid Plexuses in Multiple Sclerosis Using Conventional MRI Sequences.
    Storelli L, Pagani E, Rubin M, Margoni M, Filippi M, Rocca MA.
    J Magn Reson Imaging; 2024 May; 59(5):1643-1652. PubMed ID: 37530734
    [Abstract] [Full Text] [Related]

  • 22. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.
    Paolillo A, Pozzilli C, Gasperini C, Giugni E, Mainero C, Giuliani S, Tomassini V, Millefiorini E, Bastianello S.
    J Neurol Sci; 2000 Mar 15; 174(2):85-91. PubMed ID: 10727693
    [Abstract] [Full Text] [Related]

  • 23. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.
    Abel S, Vavasour I, Lee LE, Johnson P, Ristow S, Ackermans N, Chan J, Cross H, Laule C, Dvorak A, Schabas A, Hernández-Torres E, Tam R, Kuan AJ, Morrow SA, Wilken J, Rauscher A, Bhan V, Sayao AL, Devonshire V, Li DKB, Carruthers R, Traboulsee A, Kolind SH.
    JAMA Netw Open; 2020 Sep 01; 3(9):e2014220. PubMed ID: 32990740
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Corpus callosum atrophy and post-surgical seizures in temporal lobe epilepsy associated with hippocampal sclerosis.
    Uribe-San-Martín R, Ciampi E, Di Giacomo R, Vásquez M, Cárcamo C, Godoy J, Lo Russo G, Tassi L.
    Epilepsy Res; 2018 May 01; 142():29-35. PubMed ID: 29549794
    [Abstract] [Full Text] [Related]

  • 26. Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis.
    Fujimori J, Nakashima I.
    J Neuroimmunol; 2024 Feb 15; 387():578280. PubMed ID: 38171046
    [Abstract] [Full Text] [Related]

  • 27. Associations between corpus callosum damage, clinical disability, and surface-based homologous inter-hemispheric connectivity in multiple sclerosis.
    Russo AW, Stockel KE, Tobyne SM, Ngamsombat C, Brewer K, Nummenmaa A, Huang SY, Klawiter EC.
    Brain Struct Funct; 2022 Dec 15; 227(9):2909-2922. PubMed ID: 35536387
    [Abstract] [Full Text] [Related]

  • 28. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A, Damasceno BP, Cendes F.
    Mult Scler Relat Disord; 2015 Mar 15; 4(2):137-43. PubMed ID: 25787189
    [Abstract] [Full Text] [Related]

  • 29. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
    Lin X, Tench CR, Morgan PS, Constantinescu CS.
    J Neurol Neurosurg Psychiatry; 2008 Apr 15; 79(4):437-41. PubMed ID: 17673493
    [Abstract] [Full Text] [Related]

  • 30. Mirror movements in multiple sclerosis -a clinical, electrophysiological, and imaging study.
    Holzapfel K, Bayas A, Naumann M, Ghosh T, Steuerwald V, Allweyer M, Kirschke JS, Behrens L.
    BMC Neurol; 2024 Sep 06; 24(1):326. PubMed ID: 39242510
    [Abstract] [Full Text] [Related]

  • 31. Developing easy to perform routine MRI measurements as potential surrogates for cognitive impairment in MS.
    Morrow SA, Menon S, Rosehart H, Sharma M.
    Clin Neurol Neurosurg; 2017 Feb 06; 153():73-78. PubMed ID: 28061362
    [Abstract] [Full Text] [Related]

  • 32. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
    Llufriu S, Blanco Y, Martinez-Heras E, Casanova-Molla J, Gabilondo I, Sepulveda M, Falcon C, Berenguer J, Bargallo N, Villoslada P, Graus F, Valls-Sole J, Saiz A.
    PLoS One; 2012 Feb 06; 7(5):e37167. PubMed ID: 22606347
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
    Simon JH, Schiffer RB, Rudick RA, Herndon RM.
    AJNR Am J Neuroradiol; 1987 Feb 06; 8(4):599-604. PubMed ID: 3113196
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cognitive dysfunction and brain atrophy in Susac syndrome.
    Machado S, Jouvent E, Klein I, De Guio F, Machado C, Cohen-Aubart F, Sacré K, Papo T.
    J Neurol; 2020 Apr 06; 267(4):994-1003. PubMed ID: 31828475
    [Abstract] [Full Text] [Related]

  • 38. A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging.
    Storelli L, Azzimonti M, Gueye M, Vizzino C, Preziosa P, Tedeschi G, De Stefano N, Pantano P, Filippi M, Rocca MA.
    Invest Radiol; 2022 Jul 01; 57(7):423-432. PubMed ID: 35093968
    [Abstract] [Full Text] [Related]

  • 39. Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis.
    Figueira FF, Santos VS, Figueira GM, Silva AC.
    Arq Neuropsiquiatr; 2007 Dec 01; 65(4A):931-5. PubMed ID: 18094848
    [Abstract] [Full Text] [Related]

  • 40. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
    Kalincik T, Vaneckova M, Tyblova M, Krasensky J, Seidl Z, Havrdova E, Horakova D.
    PLoS One; 2012 Dec 01; 7(11):e50101. PubMed ID: 23166826
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.